Stockscreener 앱 받기
51.95
0.04%
0.02
전일 마감가:
$51.93
열려 있는:
$51.99
하루 거래량:
267.19K
Relative Volume:
0.64
시가총액:
$2.57B
수익:
$379.25M
순이익/손실:
$-77.34M
주가수익비율:
-32.22
EPS:
-1.6122
순현금흐름:
$-27.87M
1주 성능:
-2.50%
1개월 성능:
+3.20%
6개월 성능:
+8.27%
1년 성능:
+31.55%
1일 변동 폭
$51.08
$52.75
1주일 범위
$51.08
$53.59
52주 변동 폭
$36.20
$54.78
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
명칭
Mirum Pharmaceuticals Inc
전화
650-667-4085
주소
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
MIRM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
51.95 | 2.64B | 379.25M | -77.34M | -27.87M | -1.6122 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-19 | 재개 | H.C. Wainwright | Buy |
| 2024-04-17 | 개시 | Stifel | Buy |
| 2023-12-18 | 재확인 | H.C. Wainwright | Buy |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-11-13 | 개시 | Morgan Stanley | Overweight |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-17 | 재개 | Evercore ISI | Outperform |
| 2023-09-20 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-01 | 개시 | Citigroup | Buy |
| 2021-09-20 | 개시 | JP Morgan | Overweight |
| 2020-08-07 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | 개시 | H.C. Wainwright | Buy |
| 2020-07-31 | 개시 | Piper Sandler | Overweight |
| 2020-06-25 | 개시 | Robert W. Baird | Outperform |
| 2019-08-12 | 개시 | Citigroup | Buy |
| 2019-08-12 | 개시 | Evercore ISI | Outperform |
| 2019-08-12 | 개시 | Guggenheim | Buy |
| 2019-08-12 | 개시 | ROTH Capital | Buy |
| 2019-08-12 | 개시 | Raymond James | Outperform |
모두보기
Mirum Pharmaceuticals Inc 주식(MIRM)의 최신 뉴스
Mirum Pharmaceuticals Inc. Stock Analysis and ForecastExceptional profit velocity - jammulinksnews.com
What drives Mirum Pharmaceuticals Inc. stock priceTremendous financial leverage - Autocar Professional
What analysts say about Mirum Pharmaceuticals Inc. stockUnmatched market gains - Autocar Professional
Purpose, not just product: What sets Mirum apart - Endpoints News
Bank of New York Mellon Corp Acquires 122,402 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2025 Earnings Call Transcript - MSN
Is Mirum Pharmaceuticals Inc. a good long term investmentPhenomenal wealth increase - Autocar Professional
Mirum Pharma’s Rare Disease Bets Are Paying Off For Investors - Finimize
Mirum Gains 35% in 3 Months: How Should You Play the Stock? - MSN
Teacher Retirement System of Texas Sells 925 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Mirum Pharmaceuticals Advances Phase 3 Study on Maralixibat for Cholestatic Pruritus - TipRanks
When the Price of (MIRM) Talks, People Listen - news.stocktradersdaily.com
How Mirum Pharmaceuticals Inc. stock performs during market volatilityEntry Level Low Risk Picks - Newser
What makes Mirum Pharmaceuticals Inc. stock price move sharplyFree Access to Investment Community - Newser
Why Mirum Pharmaceuticals Inc. stock attracts strong analyst attentionMarket Beating Strategy - Newser
Mirum Pharmaceuticals stock hits all-time high at $54.46 - Investing.com Australia
Mirum Hits All-Time HighIs There More Upside Ahead? - RTTNews
Mirum Pharmaceuticals stock hits all-time high at $54.46 By Investing.com - Investing.com South Africa
Mirum Pharmaceuticals price target raised to $76 from $68 at Evercore ISI - MSN
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
KBC Group NV Makes New Investment in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Top Analyst Ratings From Last Week - The Globe and Mail
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM): Is Breakeven Near? - 富途牛牛
Mirum Pharmaceuticals (NASDAQ:MIRM) Lowered to Hold Rating by Wall Street Zen - Defense World
Mirum Pharmaceuticals beats Q1 estimates, raises 2025 guidance; shares rise - Investing.com Nigeria
Wealth Enhancement Advisory Services LLC Purchases 339 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Mirum Pharmaceuticals Insiders Sold US$2.2m Of Shares Suggesting Hesitancy - simplywall.st
Mirum Pharmaceuticals, Inc.(NasdaqGM: MIRM) dropped from Russell 3000E Index - MarketScreener
Mirum Pharmaceuticals, Inc.(NasdaqGM: MIRM) dropped from Russell Microcap Index - MarketScreener
When (MIRM) Moves Investors should Listen - news.stocktradersdaily.com
Rhumbline Advisers Purchases 2,321 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Where are the Opportunities in (MIRM) - news.stocktradersdaily.com
Insider Sell: William Fairey Sells Shares of Mirum Pharmaceutica - GuruFocus
High Growth Tech Stocks In The US Market - Yahoo Finance
Cantor Fitzgerald Predicts MIRM FY2026 Earnings - Defense World
Mirum Pharmaceuticals Expands Team with 10 New Hires, Grants $5.7M Stock Options Package - Stock Titan
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Why Is Mirum Pharmaceuticals (MIRM) Down 1.3% Since Last Earnings Report? - Yahoo Finance
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.06 Million Stock Position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Mirum Pharmaceuticals director sells shares totaling $377,843 By Investing.com - Investing.com India
Insider Sell: Saira Ramasastry Sells 8,203 Shares of Mirum Pharm - GuruFocus
Mirum Pharmaceuticals director sells shares totaling $377,843 - Investing.com Australia
Insider Sell: Saira Ramasastry Sells 8,203 Shares of Mirum Pharmaceuticals Inc (MIRM) - GuruFocus
Mirum Pharmaceuticals Inc (MIRM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):